TY - JOUR
T1 - Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor
AU - Ho, Jemima
AU - Yang, Xuexin
AU - Nikou, Spyridoula Angeliki
AU - Kichik, Nessim
AU - Donkin, Andrew
AU - Ponde, Nicole O.
AU - Richardson, Jonathan P
AU - L. Gratacap, Remi
AU - S. Archambault, Linda
AU - P. Zwirner, Christian
AU - Murciano, Celia
AU - Henley-Smith, Rhonda
AU - Thavaraj, Selvam
AU - J. Tynan, Christopher
AU - L. Gaffen, Sarah
AU - Hube, Bernhard
AU - T. Wheeler, Robert
AU - Moyes, David L
AU - Naglik, Julian R
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Candida albicans is a fungal pathobiont, able to cause epithelial cell damage and immune activation. These functions have been attributed to its secreted toxin, candidalysin, though the molecular mechanisms are poorly understood. Here, we identify epidermal growth factor receptor (EGFR) as a critical component of candidalysin-triggered immune responses. We find that both C. albicans and candidalysin activate human epithelial EGFR receptors and candidalysin-deficient fungal mutants poorly induce EGFR phosphorylation during murine oropharyngeal candidiasis. Furthermore, inhibition of EGFR impairs candidalysin-triggered MAPK signalling and release of neutrophil activating chemokines in vitro, and diminishes neutrophil recruitment, causing significant mortality in an EGFR-inhibited zebrafish swimbladder model of infection. Investigation into the mechanism of EGFR activation revealed the requirement of matrix metalloproteinases (MMPs), EGFR ligands and calcium. We thus identify a PAMP-independent mechanism of immune stimulation and highlight candidalysin and EGFR signalling components as potential targets for prophylactic and therapeutic intervention of mucosal candidiasis.
AB - Candida albicans is a fungal pathobiont, able to cause epithelial cell damage and immune activation. These functions have been attributed to its secreted toxin, candidalysin, though the molecular mechanisms are poorly understood. Here, we identify epidermal growth factor receptor (EGFR) as a critical component of candidalysin-triggered immune responses. We find that both C. albicans and candidalysin activate human epithelial EGFR receptors and candidalysin-deficient fungal mutants poorly induce EGFR phosphorylation during murine oropharyngeal candidiasis. Furthermore, inhibition of EGFR impairs candidalysin-triggered MAPK signalling and release of neutrophil activating chemokines in vitro, and diminishes neutrophil recruitment, causing significant mortality in an EGFR-inhibited zebrafish swimbladder model of infection. Investigation into the mechanism of EGFR activation revealed the requirement of matrix metalloproteinases (MMPs), EGFR ligands and calcium. We thus identify a PAMP-independent mechanism of immune stimulation and highlight candidalysin and EGFR signalling components as potential targets for prophylactic and therapeutic intervention of mucosal candidiasis.
UR - http://www.scopus.com/inward/record.url?scp=85066945576&partnerID=8YFLogxK
U2 - 10.1038/s41467-019-09915-2
DO - 10.1038/s41467-019-09915-2
M3 - Article
SN - 2041-1723
VL - 10
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 2297
ER -